spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 8 Apr 2014
MEI Pharma Adds Former VC David Urso as Senior Vice President of Corporate Development and General Counsel
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Apr 2014
Atara Biotherapeutics Strengthens Board and Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2014
Takeda Responds to Verdict in Diabetes Drug Case
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 7 Apr 2014
Alios BioPharma Raises $41 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2014
Meda and Valeant Terminates Joint Ventures
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Apr 2014
Genzyme to Resubmit Lemtrada(TM) Application for FDA Review
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Apr 2014
Statement by the Board of Directors of Meda
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Apr 2014
GTx Announces Departure of CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Apr 2014
Baxter to Acquire Chatham Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2014
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Apr 2014
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals Inc.
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Apr 2014
Immune CEO Announces New Operational Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Actavis Acquires Silom Medical Company
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 1 Apr 2014
Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 1 Apr 2014
Cubist Appoints Robert J. Perez to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Chimerix Appoints Lisa Ricciardi to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Mar 2014
Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2014
Eisai Assigns Its Worldwide Exclusive License for DACOGEN(R) to Otsuka
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Mar 2014
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2014
Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM)
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2014
Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 27 Mar 2014
Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2014
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 26 Mar 2014
Zogenix Appoints James Breitmeyer to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Mar 2014
Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN(R) In Very Young Children Born Small For Gestational Age
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2014
Kolltan Pharmaceuticals Obtains $60 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Mar 2014
Xenon and Genentech Establish New Pain Discovery Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Mar 2014
Calithera Biosciences Appoints William D. Waddill Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2014
Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2014
AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2014
Exelixis Receives Approval for COMETRIQ(R) (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2014
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 24 Mar 2014
Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Mar 2014
AMRI to Acquire Cedarburg Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2014
Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2014
Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Mar 2014
 Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT(R) (vintafolide) and Companion Imaging Agents FOLCEPRI(R) (etarfolatide) and NEOCEPRI(R) (Intravenous (IV) folic acid) in Patients with Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology Radiology Regulatory
 HSMN NewsFeed - 21 Mar 2014
Genzyme’s Lemtrada(TM) Approved in Brazil for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 20 Mar 2014
Sophiris Adds Gerald T. Proehl to its Board of Directors
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 20 Mar 2014
William R. Ringo Joins Mirati Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2014
Mirna Therapeutics Appoints Casi DeYoung as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2014
Novira Names Christian S. Schade Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2014
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2014
BioAlliance Pharma: Sitavig(R) Licensing Strategy
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 18 Mar 2014
Immune Design Appoints Franklin M. Berger to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2014
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2014
Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2014
FDA Awards Fast Track Status to Edison Pharmaceuticals' EPI-743 for Friedreich's Ataxia
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Mar 2014
Edison Pharmaceuticals Announces Initiation of EPI-743 Pearson Syndrome Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2014
Cipher Announces Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2014
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Mar 2014
Tetraphase Pharmaceuticals Adds Nancy J. Wysenski to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2014
SAGE Therapeutics Closes $38M Oversubscribed Series C Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2014
Mike Sullivan named President of Avion Pharmaceuticals, LLC
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 12 Mar 2014
Novimmune Appoints Andrew J. Oakley as CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2014
Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2014
Lumena Pharmaceuticals Raises $45 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Mar 2014
Sorrento Therapeutics Appoints Mark Durand to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Mar 2014
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR(R) (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Mar 2014
Stem Cell Therapeutics Strengthens its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Mar 2014
FlowSens(R): A New-generation Solution in CT Imaging
Biopharmaceuticals Radiology
 HSMN NewsFeed - 7 Mar 2014
Incyte Announces Positive Top-Line Results from Phase III Study of Ruxolitinib in Patients with Polycythemia Vera
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2014
Immune Design Appoints William Ringo to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Mar 2014
U.S. FDA Approves AVEED(TM) (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2014
Heat Biologics, Inc. Appoints Taylor H. Schreiber, M.D., PH.D. as Vice President of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Mar 2014
Revance to Add Angus C. Russell as Chairman to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2014
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2014
Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Mar 2014
Teva Announces Approval of Generic Evista(R) Tablets 60 mg in the United States
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 4 Mar 2014
Pernix Therapeutics Appoints Vice President of Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2014
Neos Therapeutics Completes $15.5 Million Additional Series C Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 4 Mar 2014
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Mar 2014
Vansen Pharma Inc. appoints new President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2014
PaxVax Announces New Commercial Senior Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2014
U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA
 HSMN NewsFeed - 3 Mar 2014
Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Feb 2014
Knight Therapeutics Inc. Appoints New CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2014
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2014
Abingworth Raises £225m ($375m) in its Tenth Life Sciences Fund
Biopharmaceuticals Devices Venture Capital
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2014
Arno Therapeutics Appoints Lawrence A. Kenyon Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Feb 2014
Nodality, Inc. Appoints Ralph Snyderman, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2014
Immunome Appoints New Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2014
Mirvaso(R) (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Feb 2014
Boston Therapeutics Appoints Larry K. Ellingson, Former Chair of the American Diabetes Association, as Chair of Its Scientific Advisory Board
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2014
SCYNEXIS Appoints Carole Sable, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 24 Feb 2014
Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 24 Feb 2014
BioLineRx Appoints Dr. Sandra Panem to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2014
Emergent BioSolutions Completes Acquisition of Cangene Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Feb 2014
Teva Completes Tender Offer for NuPathe Inc. Shares
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2014
Teva Receives CHMP Positive Opinion for DuoResp(R) Spiromax(R) for the Treatment of Patients Diagnosed with Asthma and COPD in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Feb 2014
ImmunoGen, Inc. Appoints Ellie Harrison as Chief Human Resources Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Feb 2014
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2014
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 19 Feb 2014
Ignyta Appoints Sara Zaknoen, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Feb 2014
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2014
Versartis Secures $55 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Feb 2014
Avillion Appoints Dr Allison Jeynes-Ellis as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2014
Bayer's Long-Acting Recombinant Factor VIII Demonstrated Prophylaxis with Less Frequent Infusions in Hemophilia A in Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2014
CoStim Pharmaceuticals, Inc. Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Feb 2014
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Feb 2014
BMG PHARMA S.r.l - Milan, Italy - Has Granted Exclusive Distribution Rights to Samyang Biopharmaceutical Corporation for GelX(R) in the Territory of South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 14 Feb 2014
AVEO and Astellas to End Worldwide Collaboration & License Agreement for Development and Commercialization of Tivozanib
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 13 Feb 2014
Principia Biopharma Expands Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!